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In this work, we have demonstrated that mesoporous silica-coated Pd@Ag nanoparticles
(Pd@Ag@mSiO2) can be used as an excellent nanoplatform for photodynamic therapy (PDT) drug
delivery. Photosensitizer molecules, Chlorin e6 (Ce6), are covalently linked to the mesoporous shell and
the prepared Pd@Ag@mSiO2–Ce6 nanoparticles exhibit excellent water solubility, good stability
against leaching and high efficiency in photo-generating cytotoxic singlet oxygen. More importantly,
the photothermal effect of Pd@Ag nanoplates under the irradiation of a NIR laser can enhance the
uptake of Pd@Ag@mSiO2–Ce6 nanoparticles by cells, further increasing the PDT efficiency toward
cancer cells. The photothermally enhanced PDT effects were demonstrated both in vitro and in vivo.
When the Pd@Ag@mSiO2–Ce6 nanoparticles were injected intratumorally into the S180 tumor-bearing
mice, the tumors were completely destroyed without recurrence of tumors upon irradiation with both
808 nm and 660 nm lasers, while the irradiation with 808 nm or 660 nm alone did not. These results
indicate that the Pd@Ag@mSiO2 nanoparticles may be a valuable new tool for application in cancer
phototherapy.1 Introduction
Photodynamic therapy (PDT) has emerged as an important
therapeutic modality for various diseases, including cancer.1
PDT is based on the concept that photosensitizers (PSs)
interact with molecular oxygen to generate reactive oxygen
species, such as singlet oxygen (1O2), upon proper light irra-
diation for the killing of cancer cells.1–4 However, the appli-
cation of many PSs in the clinic has been limited by their
nonspecic damage to normal tissues, environmental degra-
dation, and poor water solubility, which highly reduce PDT
efficacy.5 To overcome these problems, various delivery
systems have been developed for effective delivery of PSs.5–22
Among them, mesoporous silica nanoparticles (MSNs) are
promising candidates as platforms for PDT applications due to
their outstanding properties of high surface area, tunable pore
size, excellent biocompatibility, versatile surface modication
and avid cell uptake.15–22 The large surface areas and porousistry and Chemical Engineering, Xiamen
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Chemistry 2013matrix structures of MSNs not only allow signicant numbers
of PSs to be conveyed, but also help to improve the diffusivity
of ground state O2 that interacts with the PSs for effective
singlet oxygen generation.
In addition to develop various carrier vehicles, another
means of enhancing the PDT therapeutic efficacy is by
combining PDT with other treatment modalities,13,14,22–25 e.g.
hyperthermia.23–25 Hyperthermia, a procedure of raising the
temperature of tumour-loaded tissue to 40–43 C, has been used
as an adjunctive therapy with other established cancer treat-
ments such as chemotherapy.26–33 Although the clinical hyper-
thermia methods in which the heat is usually provided by
incubation chambers, radiowave irradiation or limb perfusion,
can improve the therapeutic effect of chemotherapy drugs,
however, undesirable side effects to normal organs are also
induced due to the nonspecic site heating.28–30 Recently
hyperthermia produced by near-infrared (NIR) absorbing pho-
tothermal nanomaterials such as gold nanoparticles,31,32,34,35
carbon nanotubes,36,37 graphene,38 CuS/Cu2xSe nanocrystals39
and Pd nanoplates40–42 have been extensively investigated in
cancer photothermal therapy (PTT). These nanomaterials can
strongly absorb NIR light and convert it into heat for site-
specic killing of cancer cells. A gold nanorod–photosensitizer
complex has been developed for noninvasive near-infrared
uorescence imaging and PTT/PDT dual therapy in vivo.24 It has
also been demonstrated that the photothermal effect of gra-
phene can be utilized to promote the delivery of photosensitizer
molecule, Chlorin e6 (Ce6), by mild local heating under theJ. Mater. Chem. B, 2013, 1, 1133–1141 | 1133













































View Article Onlineirradiation of lower power NIR laser upon graphene oxide (GO)–
PEG–Ce6 nanoparticles, further enhancing the cancer cell
killing during PDT treatment against cancer cells.25 These
results motivated us to further explore other NIR absorbing
nanomaterials for photothermally enhanced PDT efficacy.
Owing to their high optical absorption in the near infrared
region and excellent photothermal stability, Pd@Ag nanoplates
can effectively absorb and convert NIR light into heat.41,42
Recently we have reported the synthesis of mesoporous silica-
coated Pd@Ag nanoparticles (denoted as Pd@Ag@sSiO2@m-
SiO2 or Pd@Ag@mSiO2) loaded with anti-cancer drug, doxoru-
bicin (DOX). These nanoparticles showed a synergistic effect of
combining chemotherapy and photothermal therapy in vitro
under NIR irradiation.42
Here we demonstrate that the Pd@Ag@mSiO2 nanoparticles
can be used as an excellent nanocarrier for the photosensitizer,
Ce6, through covalent bonding (Scheme 1). The large pores and
high surface area in the mesoporous shell facilitate covalent
graing of the PSs onto the rigid porous structure, which in turn
not only increases their water solubility and stability, avoids
degradation and premature release into the systemic circulation
in harsh biological environment, but also helps to improve the
accumulation of the PS drugs in the tumor site, thereby
enhancing the PDT efficacy.19,21,22 The obtained Pd@Ag@m-
SiO2–Ce6 nanoparticles exhibit high efficiency in photo-
generating cytotoxic singlet oxygen under the irradiation with a
660 nm laser at 0.1 W cm2 power density. At the meantime, the
mild heating effect produced from the Pd@Ag nanoplates can
increase cellular membrane permeability for enhanced drug
uptake by cells.43 We observed the Pd@Ag@mSiO2–Ce6 nano-
particles-treated cells displaying stronger intracellular uores-
cence from Ce6 under the irradiation of 808 nm NIR laser than
without irradiation by both confocal microscope and ow
cytometer. These Pd@Ag@mSiO2–Ce6 nanoparticles were
injected intratumorally into the S180 tumor-bearing mice, the
tumors were completely destructed without recurrence upon
irradiation at 808 nm and 660 nm simultaneously. Our data
clearly showed that a synergism of photo and thermal effect of
Pd@Ag@mSiO2–Ce6 nanoparticles was able to enhance the
delivery of PDT agents and improve the efficiency of photody-
namic cancer cell killing.Scheme 1 Schematic image showing how to load Ce6 into Pd@Ag@mSiO2
nanoparticles and use them for PDT.
1134 | J. Mater. Chem. B, 2013, 1, 1133–11412 Experimental section
2.1 Materials
All chemicals were obtained from commercial suppliers and
used without further purication. Pd(acac)2, tetraethoxysilane
(TEOS), 3-aminopropyltriethoxysilane (APTES) and trime-
thylbenzene were purchased from Alfa Aesar. L-Arginine (Arg)
and dodecyltrimethylammonium chloride (CTAC) were
obtained from Sinopharm Chemical Reagent Co., Ltd.
(Shanghai). N,N-Dicyclohexylcarbodiimide (DCC) and 1,3-
diphenylisobenzofuran (DPBF) were purchased from Sigma-
Aldrich. Chlorin e6 (Ce6) was received from J&K Scientic
Ltd. (Beijing).
2.2 Characterization
The scanning electron microscopy (SEM) images were taken by
using a Hitachi S4800 scanning electron microscope with a eld
emission electron gun. Transmission electron microscopy
(TEM) images were obtained using a TECNAI F-30 high resolu-
tion transmission electron microscope operating at 300 kV. UV/
Vis absorption spectra were measured with a Cary 5000 UV/Vis/
NIR spectrophotometer (Varian). Dynamic light scattering (DLS)
and zeta-potential experiments were carried out on a Nano-ZS
(Malvern Instruments).
2.3 Preparation of Pd@Ag@mSiO2 nanoparticles
The Pd@Ag@mSiO2 nanoparticles were synthesized by a multi-
step method according to our recently reported protocol with
slight modications.42 First, Pd@Ag nanoplates (41 nm in
diameter) were prepared according to the procedure reported
previously.41 And then a layer of dense silica were coated onto
Pd@Ag nanoplates using a modied Stöber method. Typically,
6.17 mg of Pd@Ag nanosheets were dispersed in 128 ml of
ethanol, and 320 ml of TEOS and 2.0 ml of methylamine aqueous
solution (40%) were added in sequence. The mixture were
stirred at room temperature for 10 h, and then nanoparticles
was recovered via centrifugation at 14 500 rpm for 12 minutes,
washed three times and re-dispersed in ethanol.
The nal step is to coat a layer of mesoporous silica on the
above prepared nanoparticles.44 Typically, the above prepared
nanoparticles were re-dispersed in 120 ml of ultrapure water in
the presence of CTAC (480 mg) and trimethylbenzene (1.2 ml)
and ultrasonicated for 30 min. 160 ml of TEOS and 24.0 mg of
Arg (L-arginine) were added into the solution. Aer stirring at
45 C for 24 h, the as-prepared nanoparticles were collected by
centrifugation and washed several times with ethanol–water
mixed solution. The collected Pd@Ag@mSiO2 nanoparticles
were nally re-dispersed in ammonium nitrate ethanol solution
(1.2 g of NH4NO3 in 60 ml ethanol) at 45 C for 18 h to thor-
oughly remove the surfactant template.
2.4 Preparation of Pd@Ag@mSiO2–NH2
Porous silica coatingwasmodiedwith amine groups in order to
covalently link PSs. In a typical procedure, 30.0 mg of
Pd@Ag@mSiO2nanoparticleswere dispersed in 60.0ml ethanol,
and 60.0 ml water and 30.0 ml 3-aminopropyltriethoxysilaneThis journal is ª The Royal Society of Chemistry 2013













































View Article Online(APTES) were added. The mixture was then aged at 45 C for
overnight under magnetic stirring. The resulting Pd@Ag@m-
SiO2–NH2 nanoparticles were collected by centrifugation and
washed three times with ethanol for further use.2.5 Preparation of Pd@Ag@mSiO2–Ce6
N,N-Dicyclohexylcarbodiimide (DCC) was used as the
condensing agent to ensure that the carboxylic groups of
Chlorin e6 (Ce6) selectively reacted with the amino groups of
Pd@Ag@mSiO2–NH2 in N,N-dimethylformamide (DMF). 10 mg
of Ce6, 15 mg of DCC and 10 mg of Pd@Ag@mSiO2–NH2
nanoparticles were added to a 3.0 ml DMF solution. The
mixture was stirred at room temperature for 24 h. The obtained
Pd@Ag@mSiO2–Ce6 nanoparticles were puried through
centrifugation and washed with DMF for three times. The
supernatant which contained unreacted Ce6 molecules was
collected and used to determine the amount of Ce6 loaded onto
the Pd@Ag@mSiO2–NH2 nanoparticles by measuring the
intensity of UV/Vis spectra at 404 nm.2.6 Detection of singlet oxygen (1O2)
We used a chemical probe 1,3-diphenylisobenzofuran (DPBF) to
assess the capability of Pd@Ag@mSiO2–Ce6 nanoparticles for
singlet oxygen (1O2) generation.45 DPBF can react irreversibly
with 1O2 that causes a decrease in the DPBF absorption at
around 400 nm. In a typical experiment, 20 ml of DPBF (1.5 mg
ml1 in acetonitrile) was added into 800 ml ethanol which
contains a proper amount of Pd@Ag@mSiO2–Ce6 nano-
particles. The solutions were then irradiated with a 660 nm laser
at the light power density of 0.1 W cm2, and the absorbance at
413 nm was recorded at different periods of time. The corre-
sponding absorption of Pd@Ag@mSiO2–Ce6 nanoparticles at
413 nm was deducted.2.7 Cell culture and cellular uptake
HeLa cell line was obtained from the cell storeroom of Chinese
Academy of Science and grown in RPMI-1640 culture medium
containing 10% calf serum and 1% penicillin/streptomycin at
37 C under 5% CO2. To test the uptake of Pd@Ag@mSiO2–Ce6
nanoparticles, HeLa cells were plated in 35 mm culture dishes
at a density of about 1  105 cells per dish in RPMI-1640. Aer
culturing for 24 h, the cell medium was replaced by fresh
medium containing 40 mg ml1 of Pd@Ag@mSiO2–Ce6 nano-
particles or the same amount of free Ce6, and incubated for
different periods of time (4 and 8 h). Aer washing the cells with
PBS, uorescence imaging was performed on an Olympus
Fluoview 1000 laser-scanning microscope.
For the NIR light-promoted the uptake of HeLa cell on
Pd@Ag@mSiO2–Ce6 nanoparticles, HeLa cells were rst incu-
bated with 40 mg ml1 of nanoparticles for 2 h. Aer washing off
the unbound nanoparticles, the cells at 37 C were irradiated by
808 nm laser (0.4 W cm2) for 15 min or incubated at 42 C in
the dark for 15 min. Aer another 2 h incubation, confocal
images of cells were taken.This journal is ª The Royal Society of Chemistry 20132.8 Cytotoxicity of the Pd@Ag@mSiO2–Ce6 nanoparticles
For the cell toxicity assay, HeLa cells were pre-cultured in a
96-well plate at 1  104 per well for 24 h and then added with
Pd@Ag@mSiO2–Ce6 nanoparticles at a series of concentrations.
Aer incubation for 12 h, cell viabilities were measured by using
the standard MTT (3-(4,5)-dimethylthiahiazo-2-yl)-2,5-diphe-
nyltetrazolium bromide) assay.2.9 Photodynamic effect of the Pd@Ag@mSiO2–Ce6
nanoparticles on HeLa cells
For MTT assay, HeLa cells were seeded in 96-well cell culture
plates at a density of 1 104 per well for 24 h. Then the medium
was replaced by 200 ml cell medium containing Pd@Ag@mSiO2–
Ce6 nanoparticles at 90 or 120 mg ml1. Aer incubation for
12 h, the cells were washed three times with PBS and subjected
to different lasers irradiation for 5 min. Aer another 4 h
incubation, the standard MTT assay was carried out to deter-
mine the cell viabilities.
For optical imaging, HeLa cells were grown in a 24-well cell
culture plate at a density of 0.5  105 cells per well for 24 h.
Then 90 or 120 mg ml1 of Pd@Ag@mSiO2–Ce6 nanoparticles
were added and incubated for 12 h. Aer irradiation by different
lasers for 5 min, the cells were stained with 0.04% trypan blue
solution for 3 min. Microscopic images of cells were then
recorded using a uorescence microscope.2.10 Therapeutic efficacy of Pd@Ag@mSiO2–Ce6
nanoparticles in S180 tumor-bearing mice
Female Kunming mice (20 g) used in this study were
provided from Laboratory Animal Center of Xiamen University.
All experiments were operated according to the Animal
Management Rules of the Ministry of Health of the People's
Republic of China and the guidelines for the Care and Use of
Laboratory Animals of China. The S180 tumor model was
established by subcutaneously injecting S180 cells (2  106)
into the right rear legs in the mice. When the tumor grew to a
diameter of 7 mm, the mice were separated into ve groups
(ve mice per group) and intratumorally injected with 125 ml
of PBS or 125 ml of Pd@Ag@mSiO2–Ce6 nanoparticles (150 mg
ml1). The tumors were irradiated with the 660 nm laser (0.1
W cm2), 808 nm laser (1 W cm2), or both of them for 5 min.
Aer treatment, the tumor volume was calculated as length 
(width)2  1/2 with a caliper every two days. The relative tumor
volume was calculated as V/V0, V0 and V stand for the tumor
volume on the initial day and on the day of measurement,
respectively.2.11 In vivo NIR imaging
The S180 tumor-bearing mice were intratumorally injected with
125 ml of PBS or 125 ml of Pd@Ag@mSiO2–Ce6 nanoparticles at
150 mg ml1. The tumor on each mouse was exposed to the
808 nm laser with a power density of 1 W cm2 for 5 min, an
infrared thermography (HM-300, Guangzhou SAT Infrared
Technology Co., Ltd.) was used to capture the temperature
change on the site of the tumor.J. Mater. Chem. B, 2013, 1, 1133–1141 | 1135
Fig. 2 (a) Absorption spectra of free Ce6 and Pd@Ag@mSiO2–Ce6
nanoparticles. (b) Size distribution of Pd@Ag@mSiO2–Ce6 nanoparticles in
water. (c) Photographs of Pd@Ag@mSiO2–NH2 and Pd@Ag@mSiO2–Ce6
nanoparticles in PBS. (d) Absorption spectra of Pd@Ag@mSiO2–Ce6 nano-
particles after storing for two months and the supernatant by centrifugation.













































View Article Online3 Results and discussion
3.1 Synthesis and characterization of Pd@Ag@mSiO2–Ce6
nanoparticles
The mesoporous silica-coated Pd@Ag nanoparticles
(Pd@Ag@mSiO2) were fabricated following our recently repor-
ted procedures,42 and loaded with photosensitizer Ce6, through
covalent bonds (Scheme 1).
As shown in Fig. 1a and c, the as-prepared Pd@Ag@mSiO2
nanoparticles had an average diameter of141 nm with Pd@Ag
nanoplates (41 nm) encapsulated in a one-in-one fashion.
Obvious large pores were observed in the mesoporous shells
due to the use of trimethylbenzene (TMB) as a swelling agent for
the CTAC micelles to enlarge the pores. The large pore feature
was also conrmed by the N2 adsorption/desorption measure-
ments (Fig. S1†).
Aer reacting with 3-aminopropyltriethoxysilane (APTES),
the Pd@Ag@mSiO2 nanoparticles were modied with amino
groups. These amine-bearing particles were then crosslinked
with photosensitizer Ce6, through a covalent conjugation
strategy in which N,N-dicyclohexylcarbodiimide (DCC) was used
as the condensing agent to ensure that the carboxylic groups of
Ce6 selectively reacted with the amino groups of Pd@Ag@m-
SiO2–NH2 nanoparticles in DMF. The successful graing of Ce6
onto the nanoparticles was conrmed by the UV/Vis absorption
spectra in Fig. 2. From the UV/Vis spectra of the Pd@Ag@m-
SiO2–Ce6 nanoparticles, the characteristic Ce6 absorption
peaks were clearly identied (Fig. 2a). Based on the difference of
absorption intensity at 404 nm between the feeding Ce6
concentration and the supernatant solution which was
obtained by centrifuging the reaction solution of Pd@Ag@m-
SiO2–NH2 and Ce6 (Fig. S3†), the loading of Ce6 was calculated
to be about 25 wt% with respect to the Pd@Ag@mSiO2–NH2
nanoparticles.
Aer loading Ce6 onto the Pd@Ag@mSiO2, the morphol-
ogies and sizes of Pd@Ag@mSiO2–Ce6 nanoparticles wereFig. 1 SEM and TEM images of Pd@Ag@mSiO2 (a and c) and Pd@Ag@mSiO2–
Ce6 (b and d) nanoparticles.
1136 | J. Mater. Chem. B, 2013, 1, 1133–1141similar to those of Pd@Ag@mSiO2 (Fig. 1b and d). The size
distribution of Pd@Ag@mSiO2–Ce6 nanoparticles measured by
dynamic light scattering (DLS) is approximately 164 nm
(Fig. 2b), which is a little larger than that measured from TEM
(Fig. 1d). The as-prepared Pd@Ag@mSiO2–Ce6 nanoparticles
were well dispersed in aqueous solution and remained stable
(Fig. 2c). Owing to the robust covalent bond between Ce6 and
Pd@Ag@mSiO2–NH2, it is expected that Ce6 has a low chance of
leaking from the Pd@Ag@mSiO2–Ce6 nanoparticles when
incubated in biological environments for a long time. As
expected, aer storing for two months in phosphate-buffered
saline (PBS, pH 7.4), the nanoparticles were centrifuged and the
absorption of the supernatant was measured. As shown in
Fig. 2d, only 3.3% dye leakage from the nanoparticles was
observed, suggesting that Pd@Ag@mSiO2–Ce6 nanoparticles
are very stable against dye leaching. The good stability gives
these nanoparticles the potential for various biological appli-
cations. In addition, the zeta-potentials of Pd@Ag@mSiO2,
Pd@Ag@mSiO2–NH2 and Pd@Ag@mSiO2–Ce6 nanoparticles in
aqueous solutions at pH 7.4 were measured to be 31.3 mV,
8.24 mV and 4.86 mV (Fig. S4†), respectively.3.2 Singlet oxygen production from the Pd@Ag@mSiO2–Ce6
nanoparticles
Singlet oxygen generation is the key step in photodynamic
killing of cancer cells. To verify the production of singlet oxygen
(1O2) by the Pd@Ag@mSiO2–Ce6 nanoparticles, 1,3-diphenyl-
isobenzofuran (DPBF) was employed as a probe molecule. DPBF
reacts irreversibly with 1O2 and the reaction can be monitored
by measuring the decrease in DPBF absorption intensity at
400 nm.45 As shown in Fig. 3a, the absorption spectra of DPBFThis journal is ª The Royal Society of Chemistry 2013
Fig. 3 (a) Absorption spectra of DPBF in the presence of Pd@Ag@mSiO2–Ce6
nanoparticles after irradiation for different times with a 660 nm laser source at
0.1 W cm2. Inset: decay curves of DPBF absorption at 413 nm as a function of
irradiation time. (1) DPBF and (2) DPBF with Pd@Ag@mSiO2–Ce6 nanoparticles
solution. (b) Concentration dependence decrease in DPBF absorption (DA) by
Pd@Ag@mSiO2–Ce6 nanoparticles under the 660 nm laser irradiation,
measurement time for 2 min.













































View Article Onlinegradually decreased with 660 nm (0.1 W cm2) irradiation in the
presence of Pd@Ag@mSiO2–Ce6 nanoparticles, suggesting an
increased amount of 1O2 produced by the Ce6-conjugated
nanoparticles. In contrast, the absorption of DPBF almost
remained unchanged in the absence of Pd@Ag@mSiO2–Ce6
nanoparticles under the same experimental conditions (see
Fig. 3a inset), conrming that the decrease in absorption of
DPBF was a result of the combined effect of Pd@Ag@mSiO2–
Ce6 and the light irradiation. It is also interesting to nd that
the generation of 1O2 from the Pd@Ag@mSiO2–Ce6 nano-
particles is concentration-dependent, more 1O2 will be
produced as the nanoparticle concentrations increase (Fig. 3b).
The excellent 1O2 generation capacity by the Pd@Ag@mSiO2–
Ce6 nanoparticles inspires us to apply them in PDT treatment of
cancer cells.Fig. 4 (a) Viability of HeLa cells incubated for 12 h with different concentrations
of Pd@Ag@mSiO2–Ce6 nanoparticles. Confocal fluorescence images of HeLa
cells incubated with free Ce6 (b and c) and Pd@Ag@mSiO2–Ce6 (d and e) for 4 h
(b and d) and 8 h (c and e), respectively. The concentration of nanoparticles was
40 mg ml1 (16.7 mM Ce6).3.3 Cytotoxicity, cell uptake and in vitro PDT studies on
HeLa cells under irradiation from a 660 nm laser
Before applying these nanoparticles for the photodynamic
killing of cancer cells, the biocompatibility and cell uptake
capacity of the Pd@Ag@mSiO2–Ce6 nanoparticles were rstThis journal is ª The Royal Society of Chemistry 2013examined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide (MTT) assay and uorescence microscope
image, respectively. As shown in Fig. 4a, upon incubation with
Pd@Ag@mSiO2–Ce6 nanoparticles in the range of 0–500 mg
ml1 for 12 h, the cellular viability of HeLa cells still
remained above 75%. The MTT results indicated that the
Pd@Ag@mSiO2–Ce6 nanoparticles had low cell-cytotoxicity and
good biocompatibility.
To monitor the intracellular uptake of the Pd@Ag@mSiO2–
Ce6 nanoparticles, HeLa cells were incubated with the
Pd@Ag@mSiO2–Ce6 nanoparticles (40 mg ml
1) for 4 and 8 h at
37 C. Aer washing the unbound nanoparticles, images of the
cells were taken with a confocal uorescence microscope
(Fig. 4d and e). As shown in Fig. 4d and e, the intense red
uorescence of Ce6 was observed inside the cells and the uo-
rescence increased over incubation time. In comparison, the
intracellular uorescence signals were much weaker when HeLa
cells were incubated with the same concentrations of free Ce6
for 4 or 8 h (Fig. 4b and c). The improved Ce6 delivery efficacy byJ. Mater. Chem. B, 2013, 1, 1133–1141 | 1137













































View Article Onlinethe Pd@Ag@mSiO2–Ce6 nanoparticles was probably due to the
ease of endocytosis of the nanoparticles by cancer cells.42 The
increased uptake of Ce6-loaded Pd@Ag@mSiO2 nanoparticles
by the cancer cells is a prerequisite for PDT treatment.
The in vitro PDT effects of the Pd@Ag@mSiO2–Ce6 nano-
particles upon HeLa cells were assessed by both MTT assay and
trypan blue staining experiments. Aer incubation with
Pd@Ag@mSiO2–Ce6 nanoparticles at two different concentra-
tions of 90 and 120 mg ml1 for 12 h, the nanoparticles treated
cells were irradiated with a 660 nm laser at a power density of
0.1 W cm2 for 5 min and incubated for an additional 4 h.
Compared to the control groups without light irradiation,
the cell viabilities in the 660 nm light irradiated groups
decreased 13% (Fig. 5a) for 90 mg ml1 and 22% (Fig. 5b) for
120 mg ml1 of Pd@Ag@mSiO2–Ce6 nanoparticles, respectively.Fig. 5 In vitro photodynamic and photothermally enhanced cancer cell killing. (a
and b) cell viability data of HeLa cells incubated with Pd@Ag@mSiO2–Ce6 at 90
mg ml1 (a) and 120 mg ml1 (b) after various laser treatments. Trypan blue
stained images of HeLa cells incubated with Pd@Ag@mSiO2–Ce6 nanoparticles
at 90 mgml1 with 660 nm laser irradiation (c) and 120 mgml1 (d–h) with various
laser treatments. The power densities for 660 nm and 808 nm lasers are 0.1 W
cm2 and 1 W cm2, respectively.
1138 | J. Mater. Chem. B, 2013, 1, 1133–1141Microscopic images of trypan blue stained cells further
conrmed that the Pd@Ag@mSiO2–Ce6 nanoparticles had good
photodynamic cancer cells killing capacity (Fig. 5c and d).3.4 Photothermally enhanced PDT effects
Pd@Ag nanoplates can strongly absorb NIR light and convert it
into heat. As shown in Fig. S5,† aer silica coating, the strong
NIR absorption feature of Pd@Ag nanoplates was maintained
well. The Ce6-loaded Pd@Ag@mSiO2 nanoparticles displayed
obvious photothermal conversion effects in aqueous solution
upon irradiation with a 1 W laser at 808 nm (Fig. S6†). The
temperature of the solution containing 200 mg ml1
Pd@Ag@mSiO2–Ce6 nanoparticles was raised from 27 to
38.8 C aer irradiation for 10 min, while the temperature
almost remained unchanged for the deionized water or free Ce6
solution. Therefore, it is expected that the good NIR light
absorption capacity of the Pd@Ag@mSiO2–Ce6 nanoparticles
can be utilized to enhance the photodynamic killing efficacy of
cancer cells. To test this, HeLa cells were rst incubated with
Pd@Ag@mSiO2–Ce6 nanoparticles at two concentrations of 90
and 120 mg ml1 for 12 h. Aer washing with PBS to remove the
unbound nanoparticles, the cells were subjected to the
following handling: (1) irradiated with an 808 nm NIR laser
(1 W cm2) for 5 min; (2) rst irradiated with an 808 nm NIR
laser (1 W cm2) for 5 min which was able to induce a
temperature increase of 6 C, then the 660 nm laser (0.1 W
cm2) for 5 min (denoted as 808 nm + 660 nm); (3) simulta-
neously irradiated with the 808 nm laser (1W cm2) and 660 nm
laser (0.1 W cm2) for 5 min (denoted as simultaneous irradi-
ation or simultaneous). Microscopy images of HeLa cells aer
different treatments are shown in Fig. 5 and S7.† Compared to
cells irradiated with the 660 nm laser (0.1W cm2) alone (Fig. 5c
and d), irradiation with 808 nm and 660 nm laser in turn
(Fig. 5g and S7d†) or simultaneous irradiation (Fig. 5h and S7e†)
demonstrated an increased cell death at all test concentrations.
It was worth noting that 808 nm laser irradiation (1 W cm2, 5
min) by itself induced no obvious cell death in the
Pd@Ag@mSiO2–Ce6 nanoparticle treated cells (Fig. 5f and
S7c†). The relative cell viabilities for the above investigations
were also measured aer PDT treatments. The results agreed
with those from the uorescence microscopy experiments. With
the 808 nm NIR light prior or simultaneous irradiation with the
660 nm laser, the cell viabilities further reduced (Fig. 5a and b).
For example, with the NIR light prior to irradiation, 31% and
62% of cell growth inhibitions were achieved for the 90 and
120 mg ml1 of Pd@Ag@mSiO2–Ce6 nanoparticles, respectively,
while with the simultaneous irradiation, even higher cell growth
inhibitions of 36% and 71% were observed at concentrations of
90 and 120 mg ml1 Pd@Ag@mSiO2–Ce6 nanoparticles cases
respectively (Fig. 5a and b). These results indicated that adding
NIR light irradiation can greatly enhance the toxicity of
Pd@Ag@mSiO2–Ce6 nanoparticles, causing more cell death
than nanoparticles with only 660 nm laser irradiation.
There are two possible reasons for the increased cell death.
One is the synergistic effects of photothermal and photody-
namic therapy, the other is the photothermally enhanced theThis journal is ª The Royal Society of Chemistry 2013













































View Article OnlinePDT efficiency. As mentioned above, the 808 nm laser irradia-
tion (1 W cm2, 5 min) alone caused no obvious cell death to
Pd@Ag@mSiO2–Ce6 nanoparticles treated cells, whether the
residual heat generated by 808 nm laser irradiation causing
cells death or not, two other control experiments were con-
ducted to elucidate this. First, the Pd@Ag@mSiO2–Ce6 nano-
particle treated HeLa cells were le at room temperature for 30
min to cool down aer the 808 nm laser irradiation, and then
the 660 nm laser irradiation was applied. It was found that the
cell death rate was similar with that of without staying at room
temperature for 30 min (Fig. S8a and b†). In the second control
experiment, the Pd@Ag@mSiO2–Ce6 nanoparticle treated HeLa
cells were rstly irradiated by 660 nm laser for 5 min, then 880
nm laser for 5 min (results are shown in the ESI, Fig. S8d†), no
obvious increased cell death rate was observed in comparison
with cells treated by 660 nm laser alone (Fig. S8c†). Therefore,
we concluded that 808 nm laser irradiation can greatly improve
photodynamic killing cancer cells.
To nd out why the 808 nm laser irradiation can enhance the
PDT efficacy, we rst investigated the cell uptake of the
Pd@Ag@mSiO2–Ce6 nanoparticles with the 808 nm laser irra-
diation, which increased the temperature to about 42 C, and
without by confocal uorescence imaging. As shown in Fig. 6,
brighter red uorescence was observed inside the cells aer the
808 nm laser irradiation (Fig. 6b) compared to cell samples
without irradiation (Fig. 6a), indicating more Pd@Ag@mSiO2–
Ce6 nanoparticles were taken up by the cells. In addition, it was
found that increasing the incubation temperature to 42 C
using a water bath also led to the enhanced uptake of
Pd@Ag@mSiO2–Ce6 by cells (Fig. 6c). Ce6 uorescence from
cells measured by ow cytometry further conrmed that the
increased cellular uptake of Pd@Ag@mSiO2–Ce6 by 808 nmFig. 6 Photothermally enhanced delivery of Ce6 by Pd@Ag@mSiO2 nano-
particles. (a–c) Confocal images of HeLa cells incubated with Pd@Ag@mSiO2–
Ce6 at 37 C with (b) or without (a) 808 nm laser irradiation (0.4 W cm2, 15 min)
and cells incubated at 42 C in the dark (c) for 15 min. (d) The mean fluorescent
signal of cells treated with Pd@Ag@mSiO2–Ce6 with 808 nm laser irradiation for
15 min or not obtained from flow cytometry measurements.
This journal is ª The Royal Society of Chemistry 2013laser irradiation (Fig. 6d and S9†). With 808 nm laser
irradiation, the uorescence of Ce6 is 1.3 times greater than
that cells incubated with Pd@Ag@mSiO2–Ce6 without laser
irradiation. These results might be explained that the NIR light
irradiation induced local heating of Pd@Ag@mSiO2–Ce6
nanoparticles that are close to the cell membrane can increase
the temperature of nanoparticles-treated cells, further
increased cell membrane permeability and led to the improved
cellular uptake of Pd@Ag@mSiO2–Ce6 nanoparticles which
generated more 1O2 for killing cancer cells. Our data clearly
evidenced that the photothermal effect of Pd@Ag@mSiO2–Ce6
nanoparticles was able to enhance the delivery of PDT agents for
improved photodynamic cancer cell killing.3.5 In vivo therapeutic efficacy of Pd@Ag@mSiO2–Ce6 in
tumor-bearing mice
To investigate the therapeutic efficacy of Pd@Ag@mSiO2–Ce6
nanoparticles upon S180 tumor-bearing mice under different
laser irradiation, comparative efficacy studies were carried out.
We divided the S180 tumor-bearing mice into ve groups (n¼ 5,
where n is the number of mice in each group) and treated them
with the protocols that were listed in Table S1.† Photographs of
the mice taken before, 3 days and 7 days aer different light
irradiation and the relative tumor volume change versus time
for each group are presented in Fig. 7. As shown in Fig. 7a, the
mice treated with PBS under the simultaneous irradiation of
808 nm and 660 nm lasers (group 1) displayed tumor volume
increasing with time (black line in Fig. 7a). However, irradiation
of the tumor region by both 808 nm and 660 nm lasers aer
injection of Pd@Ag@mSiO2–Ce6 remarkably suppressed tumor
growth (pink line in Fig. 7a and b). The tumor volume was
rapidly reduced and completely disappeared aer 7 days.
Though irradiation by 660 nm laser or 808 nm laser alone aer
injection the Pd@Ag@mSiO2–Ce6 nanoparticles also sup-
pressed tumor growth to a certain degree at the initial period,
the tumor began to grow again at the later stage (blue and green
lines in Fig. 7a and b), implying that the incomplete destruction
of tumors cells by the photodynamic or photothermal treatment
can induce a recurrence of the tumor. Furthermore, the
Pd@Ag@mSiO2–Ce6 nanoparticles had no inhibitory effect on
tumor growth without light irradiation (red line in Fig. 7a),
suggesting that the nanoparticles could not produce cytotoxic
ROS or heat to inhibit tumor growth without light irradiation.
These results further revealed that the photodynamic treatment
effect of Pd@Ag@mSiO2–Ce6 nanoparticles can be improved by
the 808 nm NIR light irradiation.
It should be pointed out that compared to in vitro cell exper-
iment, better photothermal therapeutic effect of Pd@Ag@m-
SiO2–Ce6 nanoparticles was obtained in the in vivo study when
the tumor was illuminated with 808 nm laser. First, the different
amounts of accumulated Pd@Ag@mSiO2–Ce6 nanoparticles
between in vitro cells and in vivo tumor tissues may affect the
therapy outcome, since the photothermal conversion efficiency
is correlated with the concentration of nanoparticles. In our
experiment, the in vitro photothermal cell study was performed
aer washing the nanoparticles, the net temperature increaseJ. Mater. Chem. B, 2013, 1, 1133–1141 | 1139
Fig. 7 (a) Relative tumor volume change versus time for the mice treated with
PBS and Pd@Ag@mSiO2–Ce6 nanoparticles with different light irradiation,
respectively (n ¼ 5). (b) Photographs of the Pd@Ag@mSiO2–Ce6 nanoparticles
treated mice taken before, 3 days and 7 days after different laser irradiation.













































View Article Onlinewas about 6 C (the room temperature was about 33 C), which
resulted in minimal therapeutic effects. While at the tumor
tissue, aer intratumoral injecting the Pd@Ag@mSiO2–Ce6
nanoparticles, almost all the plasmonic nanomaterials accu-
mulated in the tumor sites, as a result, the temperature increased
about 16 C (from 27 to 43 C) of the tumor tissues (Fig. S10 and
S11†). Temperature rise of 16 C would partly inhibit the
growth of tumor tissue (Fig. 7a). In addition, photothermal
therapy causing tumor vascular endothelial cell injury, vascular
repair ability decline and comparatively lower oxygen level and
pH in cancer cells also might contribute to the better therapy
effects in vivo.46,47 Therefore, better in vivo therapy effect was
achieved than that of in vitro therapy.
4 Conclusions
In summary, Pd@Ag@mSiO2 nanoparticles were applied as
nanocarriers for the photosensitizer Ce6 for photothermally
enhanced photodynamic therapy studies. The Ce6 covalently
conjugated to the mesoporous silica shell exhibit excellent
stability against leaching and good efficiency in photogenerating1140 | J. Mater. Chem. B, 2013, 1, 1133–1141of reactive oxygen species. Due to the increased cellular uptake of
Ce6 delivered by the Pd@Ag@mSiO2 nanoparticles, in which the
Pd@Ag nanoplates can convert the NIR light to heat under NIR
laser irradiation, the PDT efficacy of Pd@Ag@mSiO2–Ce6 nano-
particles was greatly enhanced by irradiation with both 808 nm
and 660 nm lasers together. The prominent antitumor effects of
the Pd@Ag@mSiO2–Ce6 nanoparticles on the S180 tumor-
bearing mouse model demonstrated the promising prospect of
Pd@Ag@mSiO2 as a potential drug delivery system for in vivo
PDT-mediated cancer therapy.Acknowledgements
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